Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · IEX Real-Time Price · USD
5.42
-0.24 (-4.24%)
At close: May 31, 2024, 4:00 PM
5.51
+0.09 (1.66%)
After-hours: May 31, 2024, 6:23 PM EDT

Company Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.

It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles.

In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body.

Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos.

It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings.

Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare, Inc.
Sensus Healthcare logo
Country United States
Founded 2010
IPO Date Jun 3, 2016
Industry Medical Devices
Sector Healthcare
Employees 35
CEO Joseph C. Sardano

Contact Details

Address:
851 Broken Sound Parkway Nw, Suite 215
Boca Raton, Florida 33487
United States
Phone 561-922-5808
Website sensushealthcare.com

Stock Details

Ticker Symbol SRTS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001494891
CUSIP Number 81728J109
ISIN Number US81728J1097
Employer ID 27-1647271
SIC Code 3841

Key Executives

Name Position
Joseph C. Sardano Co-Founder, Chairman and Chief Executive Officer
Michael J. Sardano President, General Counsel, Corporate Secretary and Director
Javier Rampolla Chief Financial Officer
Magdalena Martinez Chief Operating Officer
Emiliano Sosa Chief Technology Officer
Stephanie Tipton Vice President of Marketing
Dr. Mark S. Nestor Medical Director and Member of Medical Advisory Board
Dr. Clay Jefferies Cockerell Clinical Director and Member of Medical Advisory Board

Latest SEC Filings

Date Type Title
May 31, 2024 8-K Current Report
May 20, 2024 SD Form - SD
May 10, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
Apr 29, 2024 DEF 14A Other definitive proxy statements
Apr 18, 2024 PRE 14A Other preliminary proxy statements
Mar 15, 2024 10-K Annual Report
Feb 8, 2024 8-K Current Report
Feb 6, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 2, 2024 8-K Current Report